Members of the Fluence Analytics team will attend the 2018 Workshop on Protein Aggregation and Immunogenicity. The workshop will explore clinical aspects of immunogenicity in proteins, studies of aggregate-induced immunogenicity, insights and challenges with analytical methods, and causes and controlling aggregates and particles during bioprocessing. Email email@example.com to arrange a meeting during the 2018 Workshop on Protein Aggregation and Immunogenicity.
Stephanie McCormick, the Product Manager for ARGEN, is presenting a poster during The Bioprocessing Summit 2018 which is in Boston from August 13 – 17. Stephanie’s poster will be placed in Poster Session A and is available to conference attendees on Monday and Tuesday. The poster will detail using ARGEN’s static light scattering signatures to select the top formulation candidate for a particular protein, optimized for the longest Time To Dimerization (slowest to reach a dimer).
The Bioprocessing Summit is now in its 10th year and annually attracts more than 1,000 professionals who share experienced solutions for bioprocess challenges. The conference agenda includes programs dedicated to upstream and downstream processing, analytical development, formulation development, and manufacturing.
Stephanie McCormick, the Product Manager for ARGEN, is presenting a poster during the 2018 AAPS PharmSci 360. Stephanie’s poster will discuss quickly determining protein stability through smart, multivariate formulation DOE by assessing aggregation rate and particle size. Additionally, the poster demonstrates how to effectively and efficiently develop a tailored formulation by using ARGEN to monitor aggregation under thermal and interfacial stress. Stephanie will present the poster on Wednesday, November 7 from 10:30 – 11:30 a.m, and the poster number is W1030-12-091.
AAPS PharmSci 360 is a large scientific conference with five tracks that cover all aspects of the pharmaceutical sciences. The conference attracts more than 100 exhibitors and more than 6,000 attendees from around the world on an annual basis.
Stephanie McCormick, the Product Manager for ARGEN, is presenting a poster during a Gordon Research Conference dedicated to Biotherapeutics and Vaccines Development. The conference agenda discusses critical quality attributes used to advance therapeutics and vaccines from selecting candidates through the final drug product. Stephanie’s poster includes ARGEN data generated on samples provided by Just Biotherapeutics. The data was used to develop the ideal formulation conditions for protein and peptide products.
The mission of this Gordon Research Conference is to assemble subject matter expert scientists from various fields to tackle fundamental challenges in the development of biotherapeutics and vaccines.
Please visit Fluence Analytics during PEGS Boston 2019 at booth 241! PEGS: The Essential Protein Engineering Summit is one of the industry’s preeminent events for those involved in biotherapeutic drug development. Fluence Analytics will showcase ARGEN, a lab instrument for analyzing protein and peptide aggregation and stability in real time. Fluence Analytics team members will be available to discuss applications, answer questions, and present additional content to anyone interested in analyzing molecular aggregation and stability. Anyone interested in arranging a meeting with Fluence Analytics during PEGS Boston 2019 should email info@FluenceAnalytics.com.